Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: CBIO) | Delayed: 13.17 +0.10 (0.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.07 | 52 Week High | $4.57 | |||
| Open | $13.16 | 52 Week Low | $0.62 | |||
| Day High | $13.81 | P/E | N/A | |||
| Day Low | $13.12 | EPS | $0.00 | |||
| Volume | 250,371 | |||||
